Dr. Kimberly M. Huber's lab investigates how Autism Spectrum Disorder (ASD) affects males and females differently, particularly through the lens of brain circuitry. By using mouse models, the lab explores the role of certain genes, like Pten, in creating sex-specific brain function and sensory processing challenges. Their research aims to illuminate how these differences may impact behavior and brain connectivity, providing insights that could inform future treatments for ASD.

Dr. Rong Zhang's lab at UT Southwestern Medical Center focuses on understanding how treating high blood pressure can affect brain health in older adults, particularly in relation to Alzheimer's disease. They investigate how lowering blood pressure can influence brain amyloid and tau levels, which are linked to dementia, as well as brain blood flow and overall cognitive function. The lab's research aims to provide insights that could lead to new methods for preventing and treating dementia in aging populations.

Dr. Beatriz Ma Fontoura's lab focuses on understanding the nuclear export of influenza virus mRNA and how various proteins facilitate this process. By investigating specific RNA-binding proteins and their roles in the export pathways, the lab aims to uncover fundamental mechanisms of viral replication. This knowledge could lead to new antiviral strategies against influenza virus infections.

Dr. Sarah Huen's lab at UT Southwestern Medical Center focuses on understanding how the kidney processes energy through metabolism, especially involving ketones. They investigate the role of specific enzymes in kidney cells that relate to kidney health and disease, particularly in the context of kidney injury and chronic kidney disease. By studying these mechanisms, the lab aims to find new ways to treat and prevent kidney-related metabolic disorders.

Dr. Steven L. McKnight's lab focuses on understanding how certain proteins, made up of a limited number of amino acids, play crucial roles in cellular functions. These proteins, known as low complexity domains, are often disordered and involved in various cellular processes, including the formation of RNA-rich structures in cells. The lab's research aims to uncover the mechanisms by which these proteins assemble and regulate cellular activities, with implications for understanding diseases like neurodegeneration.

Dr. Jaewon Yang's lab focuses on enhancing imaging techniques for lymphedema, a condition where fluid accumulates due to lymphatic system failure. His team is working on developing new tools to improve lymphoscintigraphy, a standard imaging method used for diagnosing lymphedema. By utilizing advanced techniques like deep learning, they aim to provide clearer images and better analysis to help improve patient care for those affected by this condition.

Dr. Nancy L. Monson's lab at UT Southwestern focuses on understanding how multiple sclerosis (MS) affects minority populations, particularly African Americans and Hispanics, who experience more severe disease progression compared to Whites. The lab investigates the role of immune responses, especially the expansion of specific immune cells called plasmablasts, in worsening the disease. The goal is to uncover mechanisms behind these disparities and develop better diagnostic and treatment strategies for MS in these populations.

Dr. Jae Mo Park's lab focuses on understanding muscular dystrophy, specifically Duchenne and Becker muscular dystrophies, which are genetic disorders that affect muscle strength and heart function. The lab is developing new non-invasive imaging techniques using MRI to identify early metabolic changes in patients, which could lead to better monitoring and treatment options for these conditions. By studying how energy is used in skeletal muscle and the heart, the lab aims to create biomarkers that can help track the progression of muscular dystrophy and improve patient care.

Dr. Weichun Lin's lab at UT Southwestern focuses on understanding how motor neurons develop and connect with skeletal muscles at the neuromuscular junction (NMJ). By studying the signals between muscles and nerves, the lab aims to discover the mechanisms that help maintain motor neurons and form healthy synapses. This research is crucial for developing effective treatments for neuromuscular diseases, especially amyotrophic lateral sclerosis (ALS).

Dr. Daniela Nicastro's research lab at UT Southwestern Medical Center focuses on understanding how cilia, tiny hair-like structures, move and function in various biological processes. The lab aims to uncover how certain protein complexes regulate ciliary movement, which is crucial for the proper functioning of many organs. By studying defects in ciliary function, the research has implications for understanding genetic disorders linked to ciliary dysfunction, such as respiratory and developmental diseases.

Dr. Julie K. Pfeiffer's lab studies how intestinal microbiota affect the infection of enteric viruses, like reoviruses. The research looks at how different strains of these viruses interact with gut bacteria and how those interactions can either enhance or inhibit viral replication. This work aims to uncover the complex relationships between viruses and the gut microbiome, which could lead to new insights into combating viral infections.

Dr. Margaret A. Phillips leads a research lab focused on developing new drugs to combat malaria, particularly in light of increasing drug resistance. Her team aims to optimize DHODH inhibitors, which can target a specific enzyme crucial for the malaria parasite's survival, using both computational models and experimental techniques. The goal is to identify safer and more effective compounds that are less likely to lead to drug resistance, thus improving treatment options for this life-threatening disease.

Dr. Martin G Pomper's lab specializes in developing innovative therapies and imaging techniques for prostate cancer, which is a significant health concern for men. They are focused on creating multimodal theranostic agents that combine diagnosis and treatment into one platform, particularly using dendrimers to target prostate-specific membrane antigen (PSMA). Their research aims to improve patient outcomes by enhancing the accuracy of cancer detection and monitoring treatment efficacy through advanced imaging methods.

Dr. You Zhang's lab focuses on advancing proton therapy for liver cancer treatment by enhancing motion management techniques. The team is developing a unique real-time imaging and proton plan adaptation system to improve the accuracy of dose delivery, which is crucial due to the challenges posed by liver motion during treatment. Their innovative approach integrates artificial intelligence and advanced imaging to ensure safer and more effective cancer radiotherapy.

Dr. Yuting Lin's research focuses on advancing radiation therapy techniques to improve cancer treatment outcomes. Her team is developing a new form of radiation therapy called proton minibeam radiotherapy (pMBRT), which aims to minimize damage to healthy tissues while effectively targeting tumors. Their work includes designing innovative treatment plans and prototypes to facilitate clinical testing of these groundbreaking therapies.

Dr. Joseph M Ready's lab studies how a specific enzyme, 15-prostaglandin dehydrogenase (15-PGDH), affects tissue healing and regeneration. They are developing small molecules that inhibit this enzyme, which could help treat various conditions involving tissue damage, such as inflammation and injury. Their research combines techniques from chemistry and biology to uncover how this enzyme functions and how its inhibition can promote recovery in the body.

Dr. Neal Mathew Alto's lab focuses on understanding how pathogenic bacteria, particularly Salmonella Typhimurium, evade the host's immune systems. They investigate the roles of specific bacterial proteins that coordinate the bacteria's division and survival within host cells. By studying these interactions, the lab aims to identify new strategies for developing drugs to combat infections caused by these bacteria.

The lab led by Dr. James J. Collins at UT Southwestern focuses on developing new therapeutic strategies to combat schistosomiasis, a disease caused by parasitic worms affecting millions worldwide. The team aims to discover and validate drug targets that can lead to the development of next-generation antischistosome therapies, addressing the urgent need for effective treatments due to rising drug resistance. By leveraging advanced techniques like RNA interference, they are identifying essential genes in schistosomes to pave the way for innovative drug discovery efforts.

Dr. Sarah H. Shahmoradian's lab focuses on understanding how the aggregation of a protein called TDP-43 causes damage to nerve cells, particularly in the context of neurodegenerative diseases like Alzheimer's and ALS. By studying how TDP-43 alters the structures in neurons known as P-bodies, the lab aims to uncover new mechanisms of neurotoxicity and identify potential markers for age-related dementia. Through advanced imaging and sequencing techniques, the research could offer insights into treating these debilitating conditions.

Dr. Helen Lai's lab at UT Southwestern is focused on understanding how spinal cord cells develop and function by creating detailed atlases that map cell types from embryonic stages to adulthood. By exploring the lineage and molecular characteristics of these cells, the research aims to connect the dots between developmental processes and the adult spinal cord, particularly in relation to senses such as touch and pain. This work will not only enhance our understanding of spinal cell types but also potentially guide regenerative medicine efforts.